GR852261B - - Google Patents
Info
- Publication number
- GR852261B GR852261B GR852261A GR850102261A GR852261B GR 852261 B GR852261 B GR 852261B GR 852261 A GR852261 A GR 852261A GR 850102261 A GR850102261 A GR 850102261A GR 852261 B GR852261 B GR 852261B
- Authority
- GR
- Greece
- Prior art keywords
- sub
- hydrogen
- amino
- hydroxy group
- new
- Prior art date
Links
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229930194542 Keto Natural products 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000468 ketone group Chemical group 0.000 abstract 1
- 239000002777 nucleoside Substances 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 abstract 1
- 125000003107 substituted aryl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Luminescent Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22739/84A IT1196261B (it) | 1984-09-20 | 1984-09-20 | Derivati nucleosidici e purinici 8-sostituiti |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR852261B true GR852261B (enExample) | 1986-01-17 |
Family
ID=11199882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR852261A GR852261B (enExample) | 1984-09-20 | 1985-09-17 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4774325A (enExample) |
| EP (1) | EP0175325B1 (enExample) |
| JP (1) | JPS61112077A (enExample) |
| AT (1) | ATE41430T1 (enExample) |
| AU (1) | AU591462B2 (enExample) |
| CA (1) | CA1268175A (enExample) |
| DE (1) | DE3568783D1 (enExample) |
| DK (1) | DK167318B1 (enExample) |
| ES (1) | ES8701773A1 (enExample) |
| GR (1) | GR852261B (enExample) |
| IT (1) | IT1196261B (enExample) |
| NZ (1) | NZ213550A (enExample) |
| PT (1) | PT81045B (enExample) |
| ZA (1) | ZA857075B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9111580D0 (en) * | 1991-05-30 | 1991-07-24 | Wellcome Found | Nucleoside derivative |
| IT1248528B (it) * | 1991-06-21 | 1995-01-19 | Pierrel Spa | Derivati di eteri e tioeteri (etero) aromatici aventi attivita` antiiperlipidemica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. |
| US5233041A (en) * | 1991-10-07 | 1993-08-03 | Glaxo Group Limited | Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a 2,3-unsaturated-1-cyclopentanylpurinone |
| ATE155467T1 (de) * | 1993-03-30 | 1997-08-15 | Sanofi Sa | Acyclische nucleosid analoge und sie enthaltende oligonucleotidsequenzen |
| US5329008A (en) * | 1993-04-07 | 1994-07-12 | Glaxo Inc. | Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone |
| US5969135A (en) * | 1995-11-02 | 1999-10-19 | Icn Pharmaceuticals, Inc. | Oligonucleotide analogs with an amino acid or a modified amino alcohol residue |
| US20060079493A1 (en) * | 2001-03-01 | 2006-04-13 | Lawrence Fritz | Methods for treating genetically- defined proliferative disorders with hsp90 inhibitors |
| US20070129334A1 (en) * | 2001-10-30 | 2007-06-07 | Conforma Therapeutics Corporation | Orally Active Purine-Based Inhibitors of Heat Shock Protein 90 |
| US7241890B2 (en) * | 2001-10-30 | 2007-07-10 | Conforma Therapeutics Corporation | Purine analogs having HSP90-inhibiting activity |
| US6906190B2 (en) * | 2002-01-04 | 2005-06-14 | Ribapharm Inc. | Inhibitors for de novo-RNA polymerases and methods of identifying targets for same |
| JP3929949B2 (ja) * | 2003-08-08 | 2007-06-13 | 独立行政法人科学技術振興機構 | 酸化により機能性ユニットを放出するヌクレオシドおよびそれを含むオリゴヌクレオチドの製造法 |
| EP2145888A1 (en) * | 2003-09-18 | 2010-01-20 | Conforma Therapeutics Corporation | Deazapurine derivatives as HSP90-Inhibitors |
| BRPI0609509A2 (pt) * | 2005-03-30 | 2010-04-13 | Conforma Therapeutics Corp | composto ou um polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso do composto, polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável |
| WO2007035963A2 (en) * | 2005-09-23 | 2007-03-29 | Conforma Therapeutics Corporation | Anti-tumor methods using multi drug resistance independent synthetic hsp90 inhibitors |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE111312C (enExample) * | 1897-12-16 | |||
| US2819260A (en) * | 1953-06-04 | 1958-01-07 | Petrolite Corp | Process for preparing oxyalkylated derivatives |
| US3391196A (en) * | 1965-08-16 | 1968-07-02 | Wyandotte Chemicals Corp | High equivalent weight hydroxy-terminated ethylene oxide-butylene oxide polyether polyols |
| US3712885A (en) * | 1968-09-10 | 1973-01-23 | G Weimann | Purine-ribofuranoside-3',5'-cyclophosphates and process for their preparation |
| JPS5133799B2 (enExample) * | 1973-06-14 | 1976-09-21 | ||
| US4048307A (en) * | 1974-12-26 | 1977-09-13 | Asahi Kasei Kogyo Kabushiki Kaisha | Cyclic adenosine monophosphate 8-substituted derivatives |
| DE2631046A1 (de) * | 1975-07-15 | 1977-01-20 | Snam Progetti | Adeninderivate und verfahren zu deren herstellung |
| SU883056A1 (ru) * | 1980-03-26 | 1981-11-23 | Ленинградский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.А.А.Жданова | Способ получени [8-(6-аминогексил)-амино]-аденозин-5-дифосфата |
| DE3027279A1 (de) * | 1980-07-18 | 1982-05-06 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| EP0045544B1 (en) * | 1980-08-06 | 1985-03-20 | Shell Internationale Researchmaatschappij B.V. | Process for the manufacture of polyether polyols and their use for preparing polyurethanes |
| JPS6094992A (ja) * | 1983-10-28 | 1985-05-28 | Sankyo Co Ltd | グリゼオ−ル酸誘導体 |
-
1984
- 1984-09-20 IT IT22739/84A patent/IT1196261B/it active
-
1985
- 1985-08-28 PT PT81045A patent/PT81045B/pt not_active IP Right Cessation
- 1985-09-16 DE DE8585111690T patent/DE3568783D1/de not_active Expired
- 1985-09-16 US US06/776,472 patent/US4774325A/en not_active Expired - Fee Related
- 1985-09-16 AT AT85111690T patent/ATE41430T1/de not_active IP Right Cessation
- 1985-09-16 EP EP85111690A patent/EP0175325B1/en not_active Expired
- 1985-09-16 ZA ZA857075A patent/ZA857075B/xx unknown
- 1985-09-17 GR GR852261A patent/GR852261B/el unknown
- 1985-09-19 DK DK426185A patent/DK167318B1/da not_active IP Right Cessation
- 1985-09-19 CA CA000491088A patent/CA1268175A/en not_active Expired - Fee Related
- 1985-09-19 NZ NZ213550A patent/NZ213550A/xx unknown
- 1985-09-19 AU AU47672/85A patent/AU591462B2/en not_active Ceased
- 1985-09-20 ES ES547856A patent/ES8701773A1/es not_active Expired
- 1985-09-20 JP JP60208571A patent/JPS61112077A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| IT8422739A0 (it) | 1984-09-20 |
| EP0175325A3 (en) | 1987-02-04 |
| EP0175325B1 (en) | 1989-03-15 |
| DK426185A (da) | 1986-03-21 |
| DK426185D0 (da) | 1985-09-19 |
| JPS61112077A (ja) | 1986-05-30 |
| ATE41430T1 (de) | 1989-04-15 |
| ZA857075B (en) | 1986-06-25 |
| ES8701773A1 (es) | 1987-01-01 |
| AU4767285A (en) | 1986-03-27 |
| JPH0569109B2 (enExample) | 1993-09-30 |
| NZ213550A (en) | 1989-06-28 |
| PT81045A (en) | 1985-09-01 |
| PT81045B (pt) | 1987-09-18 |
| IT8422739A1 (it) | 1986-03-20 |
| EP0175325A2 (en) | 1986-03-26 |
| DE3568783D1 (en) | 1989-04-20 |
| US4774325A (en) | 1988-09-27 |
| ES547856A0 (es) | 1987-01-01 |
| CA1268175A (en) | 1990-04-24 |
| AU591462B2 (en) | 1989-12-07 |
| DK167318B1 (da) | 1993-10-11 |
| IT1196261B (it) | 1988-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR852261B (enExample) | ||
| AU576555B2 (en) | 1-fluorophenylbutyl-4-(2-pyrimidinyl) piperazine derivatives | |
| PH25768A (en) | Imidazole analogs of mevalonolactone, derivatives thereof | |
| DE3579110D1 (de) | Senfgas-derivate der c-6-aminogalaktose und ihre verwendung. | |
| JPS57144298A (en) | 7-beta-d-arabinofuranosyl-7h- pyrrolo(2,3-d)pyrimidine compound and manufacture | |
| AU547111B2 (en) | Tricyclic substituted piperidylidene derivatives | |
| GB8524192D0 (en) | Low electrolyte sodium lignosulfonates | |
| GB2168350B (en) | Nucleoside derivatives | |
| EP0193903A3 (en) | Production of cytosine nucleosides | |
| AU577698B2 (en) | Gas reactor for lignites | |
| AU582770B2 (en) | Antitussive and mucus regulating 2-substituted thiazolidines | |
| IL80004A0 (en) | 7-aminoazolo(1,5-a)pyrimidines and their use as fungicides | |
| AU568186B2 (en) | Laidlomycin phenylcarbamate | |
| AU557360B2 (en) | Substituted ethenyl derivatives of 1h-pyrazolo (1,5-alpha) pyrimidine | |
| ZA822988B (en) | 5-(4-phenyl 1-piperidinyl)methyl-2,3-dihydro-2-oxo-1h-imidazole-4-carboxylic acid derivatives | |
| MY116824A (en) | Antivaral,highly water soluble,stable,crystalline salts of 2'',3''-dideoxyinosine monohydrate,2'',3''-dideoxy-2'' ,3''-didehydrothymidine monohydrate and 2'',3''-dideoxy-2''-fluoroinosine hemihydrate | |
| PT80471B (en) | Process for the preparation of 1-<3,4-dimetoxiphenetyl-amino>- 3-(m-tolyoxi)-2-propanol (bevantolol) | |
| AU1226588A (en) | A process for the preparation of 9-(hydroxyalkyl)-hypoxanthines | |
| SU1264575A1 (ru) | Способ иммобилизации клеток | |
| SU1251528A1 (ru) | Пленка - подложка для культивирования животных клеток | |
| BG49444A1 (en) | Acylureidoamynotiasolylni derivatives and method for their preparation | |
| GB8525152D0 (en) | Nucleoside derivatives | |
| IT1222864B (it) | Preparati cosmetici liposomiali | |
| WO1986001716A1 (fr) | Utilisation des derives de la pyrrothine | |
| SU892892A1 (ru) | 3-Дицианметилпиримидо-[4,5-е][1,2,4]-триазин-6,8-дион гидрат, обладающий противовоспалительной активностью |